The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome

Journal of Clinical Investigation

Volumn 97, Issue 5, 1996, Pages 1311-1318

  De Keyzer, Yves ^a,d   Lenne, Frédéric ^a   Auzan, Colette ^b   Jégou, Sylvie ^a   René, Patricia ^a   Vaudry, Hubert ^a   Kuhn, Jean Marc ^c   Luton, Jean Pierre ^a   Clauser, Eric ^b   Bertagna, Xavier ^a  

^a INSERM   (France)

^b Centre de Recherche Interdisciplinaire en Biologie   (France)

^c ROUEN UNIVERSITY HOSPITAL   (France)

^d INSTITUT COCHIN   (France)

Author keywords

Cushing's syndrome; endocrine tumors; gene expression; proopiomelanocortin; reverse transcription PCR

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; PROOPIOMELANOCORTIN; VASOPRESSIN V3 RECEPTOR;

ARTICLE; BRONCHUS CARCINOID; CLINICAL ARTICLE; CORTICOTROPIN RELEASE; CUSHING SYNDROME; ECTOPIC CORTICOTROPIN PRODUCTION; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 13344294392     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118547     Document Type: Article

References (59)

1. Iacangelo, A., H.U Affolter, L. Eidel, E. Herbert, and M. Grimes. 1986. Bovine chromogranin A, its sequence and the distribution of its messenger RNA in endocrine tissues. Nature (Lond.) 323:82-85.
2. Vieau, D., C.G. Linard, M Mbikay, F Lenne, M. Chretien, J P. Luton, and X. Bertagna. 1992 Expression of the neuroendocrine cell marker 7B2 in human ACTH secreting tumors. Clin. Endocrinol 36:597-603.
3. Seidah, N.G., R. Day, M Marcinkiewicz, S. Benjannet, and M. Chretien. 1991. Mammalian neural and endocrine pro-protein and pro-hormone convertases belonging to the subtilisin family of serine proteinases. Enzyme (Basel) 45:271-284.
4. Liddle, G W., W.E. Nicholson, D.P. Island, D.N Orth, L. Abe, and S.C Lowder. 1969. Clinical and laboratoiy studies of cctopic humoral syndromes. Recent Prog. Horm. Res. 25:283-314
5. Rees, L.H., and J.G Ratcliffe 1974. Ectopic hormone production by non-endocrine tumours. Clin. Endocrinol 3:263-299
6. de Keyzer, Y , X Bertagna, F Lenne, F Girard, J.P. Luton, and A. Kahn. 1985. Altered proopiomelanocortin gene expression in ACTH producing nonpituitary tumors J. Clin. Invest. 76:1892-1898.
7. Vieau, D , J.F Massias F. Girard, J.P. Luton, and X. Bertagna. 1989. Corticotrophin-like intermediary lobe peptide as a marker of alternate proopiomelanocortin processing in ACTH-producing non-pituitary tumours. Clin Endocrinol. 31:691-700.
8. De Bold, C.R., E.E. Mufson, J.K Menefee, and D.N Orth. 1988. Proopiomelanocortin gene expression in a pheochromocytoma using upstream transcription initiation sites Biochem Biophys Res Commun. 155:895-900.
9. Clark, A J.L., P.M. Lavender, G.M. Besser, and L.H Rees 1988. Proopiomelanocortin mRNA size heterogeneity in ACTH-dependent Cushing's syndrome J. Mol. Endocrinol. 2.3-9.
10. Lacaze-Masmonteil, T., Y. De Keyzer, J.P. Luton, A. Kahn, and X. Bertagna. 1987. Characterization of proopiomelanocortin transcripts in human non-pituitary tissues. Proc. Natl. Acad. Sci USA. 84:7261-7265
11. Bertagna, X. 1994. Proopiomelanocortin-derived peptides. In Endocrinology and Metabolism Clinics of North America. Cushing's Syndrome. D.C. Aron and J.B. Tyrrell, editors. W.B. Saunders Co., Philadelphia, PA 467-485.
12. Israel, A., and S.N Cohen. 1985 Hormonally mediated negative regulation of human proopiomelanocortin gene expression after transfection into mouse L cells. Mol. Cell. Biol. 5:2443-2453.
13. Kreisberg, R. 1994. Half a loaF. N. Engl. J. Med. 330:1295-1299.
14. Doppman, J.L. 1992. The search for occult ectopic ACTH-producing tumors. Endocrinologist. 2:41-46.
15. Mason, A.M.S., J.G. Ratcliffe, R.M. Buckle, and A.S. Mason. 1972. ACTH secretion by bronchial carcinoid tumours. Clin. Endocrinol. 1:3-25.
16. Findling, J.W., and J.B. Tyrrel. 1986. Occult ectopic secretion of corticotropin. Arch. Intern Med. 146:929-933.
17. Malchoff, C.D., D.N. Orth, C. Abboud, J.A. Carney, P.C. Pairolero, and R.M. Carey. 1988. Ectopic ACTH syndrome caused by a bronchial carcinoid tumor responsive to dexamethasone, metyrapone, and corticotropin-releasing factor. Am. J. Med. 84:760-764.
18. Federman, D.F., and E.J. Mark. 1981. Persistence of Cushing's syndrome after hypophysectomy. N Engl. J. Med 305:1637-1643.
19. Jard, S. 1985. Vasopressin receptors. Front. Horm. Res. 13:89-104.
20. Antoni, F. 1984. Novel ligand specificity of pituitary vasopressin receptors in the rat. Neuroendocrinology. 39:186-188
21. de Keyzer, Y., C. Auzan, F. Lenne, C. Beldjord, M. Thibonnier, X. Bertagna, and E. Clauser. 1994. Cloning and characterization of the human V3 pituitary vasopressin receptor. FEBS Lett. 356:215-220.
22. Sugimoto, T., M Saito, S. Mochizuki, Y. Watanabe, S. Hashimoto, and H. Kawashima. 1994. Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor. J. Biol. Chem 269:27088-27092.
23. Lolait, S.J., A -M O'Carroll, L.C Mahan, C.C. Felder, D.C. Button, W. Scott Young III, E. Mezey, and M.J. Brownstein. 1995. Extrapituitary expression of the rat V1b vasopressin receptor gene. Proc. Natl. Acad. Sci. USA. 92: 6783-6787.
24. Saito, M , T. Sugimoto, A. Tahara, and H. Kawashima. 1995. Molecular cloning and characterization of rat V1b vasopressin receptor, evidence for its expression in extra-pituitary tissues. Biochem. Biophys. Res. Commun 212: 751-757
25. Morel, A., A.M. O'Carroll, M.J. Brownstein, and S.J. Lolait. 1992. Molecular cloning and expression of a rat V1a arginine vasopressin receptor. Nature (Lond) 356:523-526.
26. Lolait, S.J., A.M. O'Carroll, O.W. McBride, M. Konig, A. Morel, and M.J. Brownstein. 1992. Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus. Nature (Lond.). 357: 336-339.
27. Birnbaumer, M., A. Seibold, S. Gilbert, J. Ishido, C. Barberis, A. Antaramian, P. Brabet, and W. Rosenthal. 1992. Molecular cloning of the receptor of human antidiuretic hormone. Nature (Lond.). 357:333-335.
28. Kimura, T , O. Tanazawa, K. Mori, M.J. Brownstein, and H Okayama 1992. Structure and expression of a human oxytocin receptor. Nature (Lond.). 356:526-529.
29. Mahlmann, S., W. Meyerhof, H. Hausmann, J. Heierhorst, C Schönrock, H. Zwiers, K. Lederis, and D. Richter. 1994. Structure, function, and phylogeny of [Arg8] vasotocin receptors from teleost fish and toad. Proc. Natl. Acad. Sci. USA. 91:1342-1345.
30. Thibonnier, M , C. Auzan, Z. Madhun, P Wilkins, L. Mattera-Berti, and E. Clauser. 1994. Molecular cloning, sequencing, and functional expression of a cDNA encoding the human V1a vasopressin receptor. J. Biol. Chem 269:3304-3310.
31. Antoni, F. A. 1988. Receptors mediating the CRH effects of vasopressin and oxytocin Ann. NY Acad. Sci. 512:195-204.
32. Jard, S., G. Gaillard, G Guillon, J. Marie, P. Schoenenberg, A.F. Muller, M Manning, and W.H. Sawyer. 1986. Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis. Mol. Pharmacol. 30:171-177.
33. Du Pasquier, D., F. Loup, M Dubois-Dauphin, J.J. Dreifuss, and E. Tribollet. 1991 Binding sites for vasopressin in the human pituitary are associated with corticotrophs and may differ from other known vasopressin receptors. J. Neuroendocrinol 3:237-247.
34. Luton, J P., J A. Mahoudeau, P. Bouchard, P. Thieblot, M Hautecouverture, D. Simon M H Laudsat, Y Touitou, and H. Bricaire. 1979. Treatment of Cushing's disease by Op'DDD. Survey of 62 cases. N. Engl. J. Med. 300:459-464.
35. Raux, M.C , M Binoux , J.P. Luton, M. Gourmelen, and F. Girard. 1975. Studies of ACTH secretion control in 116 cases of Cushing's syndrome J. Clin. Endocrinol. & Metab. 40:186-197.
36. Bertagna, X., W.E. Nicholson, G.D. Sorenson, O.S. Pettengill, C.D. Mount, and D N. Orth. 1978. Corticotropin, lipotropin, and β-endorphin production by a human nonpituitary tumor in tissue culture: evidence for a common precursor. Proc. Natl. Acad. Sci. USA. 75:5150-5164.
37. Chirgwin, J.M., A.E. Przybyla, R.J. MacDonald, and W.J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:5294-5299.
38. Sambrook, J , E.F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
39. Lefevre, H., S Jegou, P. Leroux, M. Dero, H. Vaudry, and J.M. Kuhn 1995. Characterization of the somatostatin receptor subtype in a bronchial carcinoid tumor responsible for Cushing's syndrome. J Clin. Endocrinol. & Metab. 80:1423-1428
40. Vieau, D., A. Rojas-Miranda, J M. Verley, F. Lenne, and X. Bertagna. 1991. The secretory granule peptides 7B2 and CCB are sensitive biochemical markers of neuro-endocrine bronchial tumors in man. Clin. Endocrinol. 35:319-325.
41. Creemers, J., A Roebroek, and W. Van de Ven. 1992. Expression in human lung tumor cells of the proprotein processing enzyme PC1/PC3: cloning and primary sequence of a 5Kb cDNA. FEBS Lett 300:82-88.
42. Vieau, D., N G Seidah, M. Chrétien, and X. Bertagna. 1994. Expression of the prohormone convertase PC2 correlates with the presence of CLIP in human ACTH secreting tumors. J. Clin. Endocrinol. & Metab. 79:1503-1509.
43. de Keyzer, Y., X. Bertagna, J.P. Luton, and A. Kahn. 1989. Variable modes of proopiomelanocortin gene transcription in human tumors. Mol Endocrinol 3:215-223.
44. Texier, P.L., Y. de Keyzer, R. Lacave, D. Vieau, F. Lenne, A. Rojas-Miranda, J.M. Verley, J.P. Luton, A. Kahn, and X. Bertagna. 1991 Proopiomelanocortin gene expression in normal and tumoral human lung. J. Clin. Endocrinol. & Metab 73:414-420.
45. Findling, J W., M.E. Kehoe, J.L. Shaker, and H Raff. 1991. Routine inferior petrosal sinus sampling in the differential diagnosis of adrenocorticotropin (ACTH)-dependent Cushing's syndrome: early recognition of the occult ectopic ACTH syndrome. J. Clin. Endocrinol. & Metab. 73:408-413.
46. Phlipponneau, M., M. Nocaudie, J. Epelbaum, Y. de Keyzer, J.D. Lalau, X. Marchandise, and X Bertagna. 1994. Somatostatin analogs for the localization and preoperative treatment of an ACTH-secreting bronchial carcinoid tumor. J. Clin. Endocrinol. & Metab 78:20-24.
47. Suda, T., F. Tozawa, I. Dobashi, N. Horiba, N. Ohmori, and M. Yamakado. 1993. Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro. J Clin. Invest 92:2790-2795.
48. Muglia, L J., N.A. Jenkins, D.J Gilbert, N.G. Copeland, and J.A. Majzoub 1994. Expression of the mouse corticotropin-releasing hormone gene in vivo and targeted inactivation in embryonic stem cells. J Clin. Invest 93 2066-2072.
49. Orth, D. 1992. Corticotropin-releasing hormone in humans Endocr. Rev. 13:164-191.
50. Warren, W.H , V E Gould, L.P. Fabre, C.F Kittle, and V A. Memoli. 1985 Neuroendocrine neoplasms of the bronchopulmonary tract. A classification of the spectrum of carcinoid to small cell carcinoma and intervening variants. J. Thorac. Cardiovasc. Surg. 89:819-825.
51. Milano, C.A., L.F. Allen, H.A. Rockman, P.C. Dolber, T.R. McMinn, K.R. Chien, T.D Johnson, R.A. Bond, and R. Lefkowitz. 1994. Enhanced myocardial function in transgenic mice overexpressing the Béta2-adrenergic receptor. Science (Wash. DC). 264:582-586.
52. Parma, J., L. Duprez, J. Van Sande, P. Cochaux, C. Gervy, J. Mockel, J. Dumont, and G. Vassart. 1993. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature (Lond) 365:649-651.
53. Utiger, R.D. 1966. Inappropriate antidiuresis and carcinoma of the lung: detection of arginine vasopressin in tumor extracts by immunoassay. J. Clin Endocrinol & Metab. 26:970-974.
54. Becker, K.L. 1984. Historical perspective on the pulmonary endocrine cell. In The Endocrine Lung in Health and Disease. K.L Becker and A F. Gazdar, editors. W.B Saunders Company, Philadelphia. 156-161.
55. Therrien, M , and J. Drouin. 1993. Cell-specific helix-loop-helix factor required for pituitary expression of the pro-opiomelanocortin gene. Mol. Cell Biol. 130:2342-2353.
56. Gerrero, M.R., R.J. McEvilly, E. Turner, C.R. Lin, S. O'Connell, K.J. Jenne, M.V. Hobbs, and M.G. Rosenfeld. 1993. Brn-3.0 a POU-domain protein expressed in the sensory, immune, and endocrine systems that functions on elements distinct from known octamer motifs. Proc. Natl. Acad. Sci. USA. 90: 10841-10845.
57. Picon, A., M. Leblond-Francillard, M.L. Raffin-Sanson, F. Lenne, X. Bertagna, and Y de Keyzer 1995. Functional analysis of the human proopiomelanocortin promoter in the small cell lung carcinoma cell line DMS 79. J. Mol Endocrinol 15:187-194.
58. White, A., and A. Clark. 1993. The cellular and molecular basis of the ectopic ACTH syndrome. Clin. Endocrinol. 39:131-142.
59. Stewart, P.M., S. Gibson, S.R Crosby, R. Penn, R Holder, D. Ferry, N. Thatcher, P. Phillips, D.R. London, and A. White. 1994 ACTH precursors characterize the ectopic ACTH syndrome. Clin Endocrinol 40:199-204.